Assessment of best corrected visual acuity in type 2 diabetic patients with meibomian gland dysfunction

Document Type : Original Article

Authors

1 .Ophthalmology department, faculty of medicine , Minia university.

2 Ophthalmology department ,MInia university

3 professor of ophthalmology faculty of medicine, Minia university

4 MD, department ophthalmology, faculty of medicine, Minia University

Abstract

Introduction:

Meibomian gland dysfunction (MGD)is considered an inflammatory state and a trigger for evaporative dry eye disease (DED) (1).

Aim of the study:

Assessment of visual acuity in patients with MGD including type 2 diabetic patients.

Patients and methods:

This was a case control study; the study was conducted on 90 eyes of 90 patients with meibomian gland dysfunction were randomly classified into 3 groups, and assessment of visual acuity was done in each group. The study was done in Ophthalmology department, Minia University Hospital, Egypt between December 2022 to May 2023.

Results:

There was a significant difference between the 3 groups in best corrected visual acuity (BCVA) in patients with meibomian gland dysfunction, more pronounced in patients with Diabetes mellitus (DM).

Conclusion:

In patients with MGD, BCVA was affected especially in type 2 diabetic patients. Presence of hyperglycemia leads to MGD and causes evaporative dry eye disease, which consequently leads to poor vision.

Keywords

Main Subjects

Minia Journal of Medical Research

Articles in Press, Accepted Manuscript
Available Online from 08 January 2024

Files

Share

How to cite

Statistics